These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 38296800)

  • 41. Prevalence of bronchiectasis in inflammatory bowel disease: a systematic review and meta-analysis.
    Ma Y; Qiang Z; Zhou M; Zhang T; Li Z; Zhong H; Chang Y; Ning Z; Liu Y
    Front Med (Lausanne); 2024; 11():1447716. PubMed ID: 39640979
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term efficacy and safety of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): extended follow-up of an open-label, multicentre, randomised, non-inferiority trial.
    Goodall RL; Nunn AJ; Meredith SK; Bayissa A; Bhatnagar AK; Chiang CY; Conradie F; Gopalan N; Gurumurthy M; Kirenga B; Kiria N; Meressa D; Moodliar R; Ngubane N; Rassool M; Sanders K; Solanki R; Squire SB; Teferi M; Torrea G; Tsogt B; Tudor E; Van Deun A; Rusen ID;
    Lancet Respir Med; 2024 Dec; 12(12):975-987. PubMed ID: 39366400
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effectiveness and safety of immune checkpoint inhibitors in Black patients versus White patients in a US national health system: a retrospective cohort study.
    Miller S; Jiang R; Schipper M; Fritsche LG; Strohbehn G; Wallace B; Brinzevich D; Falvello V; McMahon BH; Zamora-Resendiz R; Ramnath N; Dai X; Sankar K; Edwards DM; Allen SG; Yoo S; Crivelli S; Green MD; Bryant AK
    Lancet Oncol; 2024 Dec; 25(12):1666-1676. PubMed ID: 39551068
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interventions for supporting pregnant women's decision-making about mode of birth after a caesarean.
    Horey D; Kealy M; Davey MA; Small R; Crowther CA
    Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD010041. PubMed ID: 23897547
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sex differences in COVID-19 vaccine confidence in people living with HIV in Canada.
    Lu J; Vulesevic B; Burchell AN; Singer J; Needham J; Yang Y; Qian H; Chambers C; Samji H; Colmegna I; Del Canto S; Godin GH; Habanyama M; Hui SSC; Kroch A; Mandarino E; Margolese S; Martin C; Owino M; Lau E; Mohammadi T; Zhang W; Pelaez S; Kovacs C; Benko E; Cooper CL; Anis AH; Costiniuk CT;
    Vaccine X; 2024 Dec; 21():100566. PubMed ID: 39582795
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Infliximab for maintenance of medically-induced remission in Crohn's disease.
    Gordon M; Sinopoulou V; Akobeng AK; Sarian A; Moran GW
    Cochrane Database Syst Rev; 2024 Feb; 2(2):CD012609. PubMed ID: 38372447
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Azathioprine for people with multiple sclerosis.
    Ridley B; Nonino F; Baldin E; Casetta I; Iuliano G; Filippini G
    Cochrane Database Syst Rev; 2024 Dec; 12(12):CD015005. PubMed ID: 39651635
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs.
    Marson AG; Burnside G; Appleton R; Smith D; Leach JP; Sills G; Tudur-Smith C; Plumpton CO; Hughes DA; Williamson PR; Baker G; Balabanova S; Taylor C; Brown R; Hindley D; Howell S; Maguire M; Mohanraj R; Smith PE
    Health Technol Assess; 2021 Dec; 25(75):1-134. PubMed ID: 34931602
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Real-world clinical characteristics and therapeutic strategies in patients with moderate-to-severe inflammatory bowel disease in Argentina: Data from the RISE-AR study.
    Olivera PA; Balderramo D; Lasa JS; Zubiaurre I; Correa G; Lubrano P; Ruffinengo O; Yantorno M; Rausch A; Piñero G; Bolomo A; Amigo C; El-Hakeh J; Leonardi DB; Brion L; Sambuelli A
    Gastroenterol Hepatol; 2024 Nov; ():502287. PubMed ID: 39549817
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Concizumab prophylaxis in people with haemophilia A or haemophilia B without inhibitors (explorer8): a prospective, multicentre, open-label, randomised, phase 3a trial.
    Chowdary P; Angchaisuksiri P; Apte S; Astermark J; Benson G; Chan AKC; Jiménez Yuste V; Matsushita T; Høgh Nielsen AR; Sathar J; Sutton C; Šaulytė Trakymienė S; Tran H; Villarreal Martinez L; Wheeler AP; Windyga J; Young G; Thaung Zaw JJ; Eichler H
    Lancet Haematol; 2024 Dec; 11(12):e891-e904. PubMed ID: 39521008
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of Risk Factors, and Development and Validation of Prognostic Prediction Models for Distant Metastasis in Patients With Rectal Cancer: A Study Based on the SEER Database and a Chinese Population.
    Zhang H; Wang H; Yao Y; Liu L; Feng F; Li H; Sun C
    Cancer Control; 2024; 31():10732748241303650. PubMed ID: 39579008
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Increased risk of cardiovascular events under the treatments with Janus kinase inhibitors versus biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a retrospective longitudinal population-based study using the Japanese health insurance database.
    Sakai R; Tanaka E; Inoue E; Harigai M
    RMD Open; 2024 Jun; 10(2):. PubMed ID: 38886005
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cancer type and histology influence cutaneous immunotherapy toxicities: a multi-institutional cohort study.
    Wan G; Khattab S; Leung BW; Zhang S; Nguyen N; Tran M; Lin C; Chang C; Alexander N; Jairath R; Phillipps J; Tang K; Rajeh A; Zubiri L; Chen ST; Demehri S; Yu KH; Gusev A; Kwatra SG; LeBoeuf NR; Reynolds KL; Semenov YR
    Br J Dermatol; 2024 Jun; 191(1):117-124. PubMed ID: 38366637
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Objective responses to first-line neoadjuvant carboplatin-paclitaxel regimens for ovarian, fallopian tube, or primary peritoneal carcinoma (ICON8): post-hoc exploratory analysis of a randomised, phase 3 trial.
    Morgan RD; McNeish IA; Cook AD; James EC; Lord R; Dark G; Glasspool RM; Krell J; Parkinson C; Poole CJ; Hall M; Gallardo-Rincón D; Lockley M; Essapen S; Summers J; Anand A; Zachariah A; Williams S; Jones R; Scatchard K; Walther A; Kim JW; Sundar S; Jayson GC; Ledermann JA; Clamp AR
    Lancet Oncol; 2021 Feb; 22(2):277-288. PubMed ID: 33357510
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association between disease-modifying antirheumatic drugs for rheumatoid arthritis and risk of incident dementia: a systematic review with meta-analysis.
    Xie W; Hou Y; Xiao S; Zhang X; Zhang Z
    RMD Open; 2024 Feb; 10(1):. PubMed ID: 38413170
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Platelet-rich therapies for musculoskeletal soft tissue injuries.
    Moraes VY; Lenza M; Tamaoki MJ; Faloppa F; Belloti JC
    Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD010071. PubMed ID: 24782334
    [TBL] [Abstract][Full Text] [Related]  

  • 57. PROTON-PUMP INHIBITORS ARE ASSOCIATED WITH AN INCREASED RISK OF MICROSCOPIC COLITIS: A POPULATION-BASED STUDY AND REVIEW OF THE LITERATURE.
    Abdel-Razeq R; Boustany A; Onwuzo S; Saleh M; Gupta R; Zeid HKA; Onwuzo CN; Farhat D; Najjar M; El Alayli A; Asaad I
    Arq Gastroenterol; 2024; 61():e24053. PubMed ID: 39442126
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Impact of the COVID-19 Pandemic on Patients with Ulcerative Colitis: Results from a Global Ulcerative Colitis Narrative Patient Survey.
    Peyrin-Biroulet L; Ylänne K; Sipes A; Segovia M; Gardiner S; Cappelleri JC; Mulvey A; Panaccione R
    Adv Ther; 2024 Feb; 41(2):598-617. PubMed ID: 38048018
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Drug therapy for obstructive sleep apnoea in adults.
    Mason M; Welsh EJ; Smith I
    Cochrane Database Syst Rev; 2013 May; 2013(5):CD003002. PubMed ID: 23728641
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.